NORCET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norcet, and what generic alternatives are available?
Norcet is a drug marketed by Abana and is included in one NDA.
The generic ingredient in NORCET is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORCET?
- What are the global sales for NORCET?
- What is Average Wholesale Price for NORCET?
Summary for NORCET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
DailyMed Link: | NORCET at DailyMed |
US Patents and Regulatory Information for NORCET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abana | NORCET | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 088871-001 | May 15, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |